U.S. Botulinum Toxin Market Size & Outlook, 2023-2030
U.S. botulinum toxin market, 2018-2030 (US$M)
Related Markets
U.S. botulinum toxin market highlights
- The U.S. botulinum toxin market generated a revenue of USD 4,674.9 million in 2023 and is expected to reach USD 9,019.0 million by 2030.
- The U.S. market is expected to grow at a CAGR of 9.8% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2023 | USD 4,674.9 million |
| Market revenue in 2030 | USD 9,019.0 million |
| Growth rate | 9.8% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, U.S. accounted for 42.1% of the global botulinum toxin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. botulinum toxin market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 9,019.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.95% in 2023. Horizon Databook has segmented the U.S. botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
The botulinum toxin market in the U.S. accounted for 79.5% of North America’s market. High disposable income and growing awareness about the availability of a variety of esthetic procedures are some of the factors responsible for market growth.
According to an article published by the American Society of Plastic Surgeons, around 7,347,900 noninvasive esthetic procedures were performed in the country in 2021, of which 2,520,000 were botulinum toxin fillers accounting for 47.1% of the total noninvasive treatments performed in the country.
This can be attributed to factors such as technological advancements, relatively higher disposable income, and availability of a number of esthetic procedures in the country. In addition, adoption among millennials tripled in the past 4 years in the U.S., accounting for over 1 million individuals undergoing esthetic procedures in 2018.
Reasons to subscribe to U.S. botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into U.S. botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. botulinum toxin market size, by product, 2018-2030 (US$M)
U.S. Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
